Abstract Theiler's murine encephalomyelitis virus (TMEV) induces demyelination in susceptible strains of mice (SJL/J) through an immunopathological process that is mediated by CD4 + Th1 T cell. These T cells are chemoattracted to the central nervous system by chemokines. Hence, in this study, we focused on the production of the chemokine "interferongamma-inducible protein 10 kDa," or IP-10/CXCL10, by cultured SJL/J mouse astrocytes infected with the BeAn strain of TMEV and its capacity to attract activated T cells. The analysis of the whole murine genome by DNA hybridization with cRNAs from mock-and TMEV-infected cultures revealed the upregulation of six sequences that potentially encode for CXCL10. This increased CXCL10 expression was validated by PCR and qPCR. The presence of this chemokine was further demonstrated by enzyme-linked immunoassay (ELISA). Significantly, astrocytes from BALB/c mice, a strain resistant to demyelination, did not produce CXCL10. The secreted CXCL10 was biologically active, inducing chemoattraction of activated lymphocytes. The inflammatory cytokines, IL-1α, IFN-γ, and TNF-α, were strong inducers of CXCL10 in astrocytes. Serum from TMEV-infected SJL/J but not BALB/c mice contains CXCL10, the levels of which peak at the onset of the clinical disease. Finally, this in vitro inflammation model was fully inhibited by 17β-estradiol and four selective estrogen receptor modulators, as demonstrated by ELISA and qPCR.
Introduction
Theiler's murine encephalomyelitis virus (TMEV) is a picornavirus that persistently infects the murine central nervous system (CNS) (Theiler 1937) . After inoculation of the BeAn low-neurovirulence strain into the brain, genetically susceptible strains of mice develop a chronic demyelinating disease that represents an useful experimental model for multiple sclerosis (MS; Clatch et al. 1986 ). In this model, myelin breakdown is mediated by the immune system rather than being a direct consequence of viral infection of oligodendrocytes, the myelin-forming cells (Lipton and Dal Canto 1976; Rossi et al. 1991; Roos et al. 1982) . Mononuclear immune cell infiltration is observed in the demyelinating areas of inflammation within the white matter of the brain and spinal cord, and this produces a strong delayed type hypersensitivity (DTH) reaction (Clatch et al. 1986 ). In the present study, we focused our attention on the chemoattraction of activated T cells, TMEV-specific CD4 + T cells that trigger demyelination through a nonspecific bystander response (Clatch et al. 1986 ).
Many cell types rely on cellular movement in order to participate in important biological processes, such as the response to viral infection (Bajetto et al. 2002) . Chemotactic cytokines or chemokines are a family of small proteins that drive leukocyte migration, and by mobilizing the actin cytoskeleton, chemokines allow leukocytes to penetrate the CNS through the blood vessel endothelium. Therefore, as molecules involved in the recruitment and influx of immune cells, these chemokines could be directly involved in TMEVinduced demyelination.
Different chemokines interact with distinct responsive immune cells via their specific transmembrane G proteincoupled receptors. Some chemokines attract neutrophils, such as CXCL1/KC and CXCL2/MIP-2, the first line in the cell's innate defense system (Natham 2006; Rubio et al. 2006; Rubio and Sanz-Rodriguez 2007) , while other chemokines interact with macrophages and monocytes, such as CCL5/RANTES (Appay and Rowland-Jones 2001) . Finally, some chemokines attract resting T lymphocytes, such as CXCL12/SDF-1α (stromal cell-derived factor-1α) or activated T lymphocytes, such as CXCL10/IP-10 (interferon-gamma-inducible protein 10 kDa; Dufour et al. 2002) .
Human and simian astrocytes, as well as other cells like the microvascular endothelial cells, are induced to produce several chemokines after specific inflammatory stimuli (CroitoruLamoury et al. 2003; Salmaggi et al. 2002) . In patients with an acute MS pathology, expression of the CXCL10 chemokine is upregulated in the serum (Franciotta et al. 2001) , cerebrospinal fluid (CSF; Narikawa et al. 2004) , astrocytes (Simpson et al. 2000) , and in macrophages/monocytes (Balashov et al. 1999) . Astrocytes from patients with Aicardi-Goutieres syndrome also synthesize CXCL10 (Van Heteren et al. 2008) , and mouse astrocytes also express messenger RNAs (mRNAs) encoding for several chemokines (Palma and Kim 2001; Kang et al. 2008 ). As such, 24 chemokines of the CC (19 chemokines), CXC (4), and CX3C (1) families have been shown to attract activated T lymphocytes to date.
The ability of TMEV to induce the secretion of CXCL10 has been well established (Theil et al. 2000; Tsunoda et al. 2004; Carpentier et al. 2007; Kang et al. 2008 ). Furthermore, 11,100 functional interferon-γ receptors were shown to be present on the cell surface of SJL/J astrocytes (with a Kd= 1.64×10 −9 M; Rubio and de Felipe 1991) . Thus, we have focused our attention on the molecular biology of this interferon-γ-inducible gene, the biological activity of its product, and on its inhibition by some selected estrogen receptor modulators (SERMs). This CXCL10 chemokine exerts a strong attractive influence on activated T lymphocytes, and it is the most relevant chemokine in our neurovirological experimental model. Astrocytes are one of the cellular targets of estradiol and estrogenic compounds (Acaz-Fonseca et al. 2014) , and astrocytes that express the alpha estrogen receptor (αER) mediate estrogenic anti-inflammatory effects in an experimental model of MS (Spence et al. 2011 (Spence et al. , 2013 . Therefore, in this study, we explored whether estradiol and some selective SERMs regulate the induction of the CXCL10 expression in astrocytes by TMEV.
Materials and methods

Astrocyte cultures
Astrocyte cultures were prepared through mechanical dissociation of the cerebral cortex from newborn SJL/J and BALB/c Cum mice (Rubio et al. 2003) . The cortex was isolated under a dissecting microscope and cleared of choroid plexus and meninges. Cell suspensions obtained were filtered through 135-μm pore size mesh into Dulbecco's modified Eagle medium (DMEM) containing 10 % fetal calf serum (FCS) and penicillin-streptomycin (Gibco BRL, Paisley, Scotland). After centrifugation, the cells were filtered through a 40-μm nylon cell strainer (Falcon-Becton Dickinson, Le Pont De Claix, France) and then cultured at 37°C in 75-cm 2 tissue culture flasks (Costar, Cambridge, MA). The medium was changed after 4 days in culture and subsequently twice a week for the entire culture period. The cultures were enriched in astrocytes through the removal of less adherent microglia and oligodendrocytes after shaking overnight at 37°C at 250 rpm on a table top shaker (Thermo Forma, Marietta, OH). Cell confluence was observed at 10 days after plating, producing approximately 1×10 7 cells per flask, the cells displaying a polygonal flat morphology. A mean of 98 % astrocytes was confirmed by indirect immunofluorescence staining of methanol-fixed cultures with a rabbit antiserum raised against glial fibrillary acidic protein (GFAP; Dakopatts, Glostrup, Denmark). The absence of mature oligodendrocytes or microglia cells was determined using a guinea pig anti-myelin basic protein (MBP) antiserum prepared as described elsewhere (Rubio et al. 2003 ) and a monoclonal anti-Mac-1 antibody (Serotec, Oxford, UK). Secondary fluorescein-conjugated antibodies were purchased from Sigma Chemical Co. (St. Louis, MO).
Viruses and infection
For these studies, a strain of TMEV isolated in 1957 from a feral mouse in Belem, Brazil, called BeAn 8386, was used. Baby hamster kidney cells (BHK-21) were grown at 37°C in DMEM containing 10 % FCS and penicillin-streptomycin, and they were infected for 48 h at 33°C. After sonicating and centrifugation in the cold to remove cell debris, virus titers of the stocks in plaque-forming units (PFUs)/mL were determined using a standard plaque assay on BHK-21 cells with 1 % Noble agar (Difco Laboratories, Detroit, MI) and staining with 0.2 % crystal violet in 20 % methanol. The multiplicities of infection (m.o.i.) were defined as the number of PFU used to infect a single cell. No changes in cell viability were detected after infection at an m.o.i. of 10, as determined with 0.4 % Trypan blue (Gibco BRL), although the percentage of infected cells was almost 100 % 24-h post-infection (Rubio et al. 2003) . A low PFU output from BeAn-infected astrocyte supernatants (5-30×10 5 PFU/mL, equivalent to 0.2-1.2 PFU/ cell) was demonstrated by titration in the plaque assay (Rubio et al. 2003) . The cells used for mock infections were incubated with a virus-free BHK-21 cell lysate. For UV light virus inactivation, viral samples were irradiated at 560 μW/cm 2 for 15 min, conditions that produced inactivated viral stocks devoid of infectious virus, as determined in plaque assays (<10 PFU/mL).
cRNA target preparation and DNA hybridization At least three different SJL/J astrocyte cultures infected at an m.o.i. of 10 were harvested 4-h post-infection. The cells were washed with phosphate-buffered saline (PBS), and total RNA was isolated using the TRIzol reagent (Gibco BRL), followed by a further purification with RNeasy Mini Kit (Qiagen, Valencia, CA). Samples of 10 μg of RNA were converted to complementary DNA (cDNA) using the SuperScript Choice System kit (Gibco BRL). Second-strand synthesis was performed using T4 DNA polymerase, and the cDNA was isolated through phenol-chloroform extraction. The cDNA isolated was transcribed using the BioArray High Yield RNA transcript Labeling Kit (Enzo Biochem, New York, NY) with biotin-labeled UTP and CTP to produce biotin-labeled complementary RNA (cRNA). The labeled cRNA was isolated using the RNeasy Mini Kit and fragmented in 100 mM potassium acetate-30 mM magnesium acetate-40 mM Trisacetate (pH 8.1) buffer for 30 min at 94°C. Hybridization performance was analyzed using test 2 arrays (Affymetrix, Santa Clara, CA) with spike and housekeeping controls. The target cRNA was hybridized to the murine genome U74v2 microarray (Affymetrix) following the manufacturer's protocols. Briefly, 15 μg of fragmented cRNA was hybridized for 16 h at 45°C with constant rotation (60 rpm). The microarrays were then washed and stained with streptavidin-conjugated phycoerythrin (SAPE) using the Affymetrix GeneChip Fluidic Station 400. All hybridization steps were performed at Progenika Ltd, Derio, Spain. Each gene on the U74v2 array is represented by 20 different 25-base cDNA oligonucleotides complementary to a cRNA target transcript (perfect match). As a control of hybridization specificity, an oligonucleotide containing a single-base substitution corresponding to each perfect match cDNA oligonucleotide (mismatch) was represented on the array. The combination of perfect match and mismatch cDNA oligonucleotides for each gene is termed a probe set. By using Affymetrix-defined absolute mathematical algorithms describing perfect match and mismatch intensities, each gene was defined as absent or present and assigned a value. The binding intensity values were scaled to evaluate differential expression following TMEV virus infection.
Based on the Affymetrix-defined mathematical algorithms for comparison, a virus-induced transcript was classified as unchanged, marginally increased, marginally decreased, increased or decreased. The changes were quantified using the signal log ratio corresponding to log 2 of the fold change for each gene. The standard errors in mean transcriptional expression of a gene were also calculated.
RT-PCR analysis of CXCL10 mRNA expression Total RNA from mock-or TMEV-infected astrocyte cultures was purified using the RNeasy Mini purification kit (Qiagen). The samples were reverse transcribed using Moloney murine leukemia virus reverse transcriptase (RT) (Promega, Madison, WI) and the 3′ amplimer as template/primer. The amplimers used for mouse CXCL10 amplification were synthesized at Sigma-Genosys Ltd (Gene Bank accession number NM_021274).
Forward: CCTATCCTGCCCACGTGTTGAG Reverse: CGCACCTCCACATAGCTTACAG A primer set for mouse β-actin was used as housekeeping positive control, also from Sigma-Genosys Ltd:
Forward: GTGGGCCGCCCTAGGCACCA Reverse: CTCTTTGATGTCACGCACGATTTC The primers were designed according to the results of a Primer-Blast analysis. The cycling conditions of the RT-PCR reactions were the following: denaturation at 94°C for 1 min, annealing at 62°C for 1 min, and extension at 72°C for 1 min. This was repeated for 30 cycles and followed by a final 10-min extension at 72°C, using a Perkin Elmer Cetus 480 DNA thermal cycler. The resulting PCR products were purified using S-400 MicroSpin columns (Pharmacia Biotech, Uppsala, Sweden) and electrophoresed in 2 % NuSieve agarose gels (FMC Bio Products, Rockland, ME) in TAE buffer, stained with ethidium bromide, and photographed in a Gel station system (TDI, Barcelona, Spain). The DNA molecular weight marker used was pBR322 DNA-MspI digest from New England Biolabs, Beverly, MA.
Quantitative real-time PCR Total RNA was extracted from mock-or TMEV-infected astrocyte cultures with the RNeasy Mini purification kit (Qiagen), and cDNAs were prepared using Moloney murine leukemia virus RT (Promega) and the 3′ amplimer as template/ primer. Quantitative real-time RT-PCR (qPCR) was performed using an ABI PRISM 7000 Sequence Detector System (Applied Biosystems, Weiterstadt, Germany). Specific qPCR primers for mouse CXCL10 were synthesized by INVITROGEN™, CEDEX 95613, Cergy Pontoise, France.
Forward: CAGTGAGAATGAGGGCCATAGG Reverse: CGGATTCAGACATCTCTGCTCAT The qPCR reactions were performed in a 20-μL reaction volume using the SYBR® Green PCR Master Mix from Applied Biosystems. Reactions were performed in triplicate. The standard curves for CXCL10 and β-actin as control housekeeping gene were generated using serial dilutions of cDNAs from astrocytes, and CXCL10 expression was normalized to β-actin expression using the standard curve method described by the manufacturer. The data were analyzed using the 7000 System SDS software from Applied Biosystems and expressed as the means±SEM in box plots.
Western blots of astrocyte supernatants
Astrocyte supernatants from at least three independently prepared cultures of mock-and TMEV-infected SJL/J cells were centrifuged, frozen into aliquots, and stored at −80°C until further use. The samples were boiled with 20-mM Tris-HCl buffer (pH 7.4), 1 mM MgCl 2 , 1 mM PMSF, 10 μg/mL leupeptin (Sigma) containing 1 % SDS and 1 % β-mercaptoethanol. After electrophoresis on 12 % polyacrylamide gels, the separated proteins were transferred to nitocellulose membranes and blocked with 10 % nonfat milk in Tris buffer. The primary antibody used was anti-mouse CXCL10 affinity-purified goat IgG antibodies from R&D Systems (Catalog number AF-466-NA). After washing in Tris-HCl (pH 7.4), containing 0.1 % Tween, the membranes were incubated for 2 h at room temperature with Protein Ahorseradish peroxidase (Pharmacia Biotech) diluted 1:5,000. After three washes with Tris buffer 0.1 % Tween, the protein bands were visualized by enhanced chemiluminescence (ECL, Amersham Biosciences, UK).
ELISA determination of CXCL10
Enzyme-linked immunoassays (ELISAs) were performed using the Quantikine® Immunoassay kit for mouse CXCL10/IP-10 (R&D Systems, Minneapolis, MN). It has a limit of detection of 1.2-4.2 pg/mL, and there is no crossreactivity with other chemokines as KC, Mig, or SDF-1α.
T lymphocyte migration assay of biological activity A variant of the murine CD4 + T helper cell clone D 10 (Ojeda et al. 1995) that is continuously activated in the presence of IL-2 was used in the activated T cell migration assay. These cells were maintained in Click's EHAA medium (Gibco BRL) supplemented with 10 % FCS and 5 IU/mL of recombinant IL-2 (Hoffman-La Roche Inc. Nutley, NJ). The D 10 cells were washed and resuspended in DMEM, with no detectable loss of viability, evident in the Trypan blue exclusion assay (>98 % viable). Chemotaxis assays were conducted in transwell chambers with 5-μm pore size membranes (Costar, Cambridge, MA). Briefly, each upper chamber was loaded with 25,000 cells in a volume of 500 μL of DMEM, and 600 μL of the different dilutions of TMEV-infected astrocyte culture medium was added to the lower chamber, and the transwells were incubated for 3 h at 37°C in 5 % CO 2 . The cells were collected from the lower compartment, centrifuged, resuspended, and quantified by flow cytometery (Coulter EPICS-XL). The CD4 + T helper cells (clone D 10) were stained by an anti-CD4 antibody from BD BiosciencesPharmingen, San Diego, CA. For antibody neutralization, samples of undiluted astrocyte supernatants were incubated for 1 h at 37°C with different concentrations of anti-mouse CXCL10 affinity-purified goat IgG antibodies from R&D Systems. Residual activity was determined in the migration bioassay for T lymphocytes. As a negative control, an anti-CXCL1 goat IgG antibody from R&D Systems was used.
Cytokine treatments
In another series of experiments, cells were treated for 48 h at 37°C with 10 ng/mL of the following mouse recombinant proinflammatory cytokines: mouse recombinant IL-1α (Genzyme, Cambridge, MA); recombinant murine interferon-γ (IFN-γ) (Holland Biotechnology, Leiden, The Netherlands); recombinant murine tumor necrosis factor-α (TNF-α) from Innogenetics, Antwerp, Belgium, and recombinant IL-6 (Boehringer Mannheim, Germany). After the treatments, the supernatants were tested for the presence of CXCL10 using the aforementioned ELISA.
Intracerebral inoculation of mice
Six-week-old SJL/J or BALB/c mice were anesthetized with Fluothane®, and a 20 μL of a suspension of BeAn virus (2× 10 6 PFU) was injected into the right cerebral hemisphere using a 25-μL Hamilton syringe. Blood was obtained on different days of post-inoculation, and the serum was frozen at −20°C until it was used further.
Estrogen inhibition of TMEV-induced CXCL10 induction
Cultures of astrocytes were infected with TMEVat an m.o.i. of 10 and, after 24 h, were washed with culture medium and treated with a concentration of 17β-estradiol of 10 −11 M diluted in medium from a 100× stock prepared in DMSO. The 17β-estradiol and the selective estrogen receptor modulators (SERMs), tamoxifen and raloxifene, were purchased from Sigma. Ospemifene and bazedoxifene were synthesized according to DeGregorio et al. (1996) and Raveendranath et al. (1998) , respectively. All the SERMs were used at a concentration of 10 −9 M, also diluted from 100× stocks prepared in DMSO. After a further 24 h in the presence of the ligands, the supernatants were harvested, centrifuged, and tested for the presence of CXCL10 by ELISA. Total RNA was extracted from the same cultures using the RNeasy Mini purification kit (Qiagen) and analyzed by quantitative realtime RT-PCR performed as indicated above.
Results
DNA hybridization shows upregulation of CXCL10
The whole genome DNA hybridization microarray analysis allowed a comparison of the gene expression profile of sham-infected or TMEV (BeAn strain)-infected astrocytes. The purpose of doing the chip analysis was to characterize the overall upregulation and downregulation of cellular genes induced by this infection. After infection at an m.o.i. of 10, analysis of the Affymetrix mouse gene expression SE437 and SE438 GeneChips revealed that six sequences with an UniGene database hit description of "IFN-γ-activated gene" or "IFN-γ-stimulated protein" were upregulated in astrocytes (Table 1 ). The six upregulated sequences exhibit fold changes (2× signal log ratio) increased values ranging from 14.4 to 5.2. Two of them were located on mouse chromosome number 1 and another one in chromosome 19. Therefore, our DNA array gene expression analysis indicated that TMEV infection provoked the overexpression of an "interferon-gamma-inducible protein" that could be, among others, the chemokine functionally known as IP-10 having the systematic name of CXCL10, a pre-eminent chemokine that attracts T activated lymphocytes. Accordingly, we set out to further characterize this chemokine.
RT-PCR and qPCR
The data obtained by microarray DNA hybridization was validated both by RT-PCR and qPCR approaches. The presence of CXCL10 mRNA in TMEV-infected SJL/J astrocyte cultures was first determined by RT-PCR, using specific primers to amplify a fragment clearly overexpressed in the cultures infected at increasing m.o.i.'s (Fig. 1, upper panel) . A study of the kinetics showed the early presence of CXCL10 mRNA 2-h post-infection (p.i.) which peaked at 4 h and that returned to background levels at 24 h p.i. Negative controls, in which the Moloney murine leukemia virus RT was omitted, yielded no bands (not shown). Moreover, the structural housekeeping β-actin gene was amplified as a positive control (Fig. 1, lower panel) . The expression of CXCL10 mRNA was quantified by realtime PCR (qPCR), a sensitive and quick technique for nucleic acid quantification. The qPCR box plot in Fig. 2 showed that at 4 h p.i., mRNA synthesis for CXCL10 increased 3.5-and 8.5-folds (50th percentile) at m.o.i.'s of 1 and 10, respectively, (P<0.01). A maximal increase was found at 4 h p.i., reaching a relative mRNA expression of 20 compared with the mockinfected cultures that were assigned a value of 1. These differences validated the changes observed in the microarray DNA hybridization analysis.
Western blot of CXCL10 in supernatants
The secretion of CXCL10 was studied in Western blots of supernatants from astrocyte cultures uninfected (0) or from those infected at different m.o.i.'s (0.1-10) (Fig. 3, upper  panel) . Faint protein bands were evident at an m.o.i. of 1 and 10 while no bands were detected in the uninfected cultures or in those infected at an m.o.i. of 0.1. The maximum loading volume of 20 μL of supernatant per lane in the SDS-PAGE electrophoresis allows a protein loading of around 0.5 ng of Table 1 TMEV-induced upregulation of sequences annotated as belonging to "interferon-gamma-activated gene" or "interferon-gamma-stimulated protein" in the UniGene database. All changes were significant based on the triplicate analysis of the signal log ratios (Sambrook et al. 1989 ).
ELISA quantification of CXCL10
Conversely, using the Quantikine® mouse CXCL10 ELISA kit, there was a clear accumulation of CXCL10 in the supernatants from infected astrocytes. Some samples were diluted 1:10 in order to enter in the range of the test, which has a limit of detection of 1.2-4.2 pg/mL and was therefore 100-400 times more sensitive than the Western blotting. Some basal CXCL10 production was evident in supernatants from mockinfected cultures (0, Fig. 3 , panel a, black bars). This basal production was similar to that obtained infecting astrocytes with UV light-inactivated BeAn virus (not shown). There were statistically significant increases in the production of the chemokine in cultures infected at m.o.i.'s of 0.1-10, reaching a plateau at m.o.i.'s of 1 and 10 (Fig. 3a) . When we explored the kinetics of CXCL10 production over periods ranging from 2 to 24 h p.i., after infection at m.o.i. of 10, we detected maximal accumulation in the supernatant after 24 h (Fig. 3b) , despite the fact that there is no mRNA synthesis at that time (see Figs. 1 and 2) . Moreover, astrocytes from BALB/c mice, a strain resistant to TMEV demyelination, did not produce significant levels of CXCL10 (Fig. 3 , empty bars) when infected in the same conditions as SJL/J astrocytes. Nevertheless, BALB/c astrocytes were susceptible to TMEV infection to the same extent as SJL/J astrocytes, both producing titers of around 5-30×10 5 PFU/mL, when measured by titration of the supernatants on BHK-21 cells (m.o.i. of 10, 24 h; Rubio et al. 2003) . This strain-dependent difference in CXCL10 expression suggests a role for this chemokine in attracting immune cells within the CNS in susceptible mice, which in turn might trigger demyelination in this experimental model of MS.
Biological chemoattracting activity of astrocyte supernatants
One characteristic of T cell activation is the expression on the cell surface of transmembrane receptors for cytokines and chemokines, including the receptor for CXCL10, that is not expressed by naive T lymphocytes. The chemoattracting activity of TMEV-infected astrocyte supernatants was studied by flow cytometry on activated (CD4 + ) T lymphocytes. As shown in Fig. 4 , the supernatants of infected cells strongly attracted activated T cells (the murine CD4 + T helper D10 cell line activated by IL-2) whereas the supernatants from mockinfected cultures do not show any attracting activity (data not shown). The D 10 cell line used here has the same phenotype (CD4 + T helper) as cells triggering the DTH reaction that produces demyelination in the TMEV system (Clatch et al. 1986 ). Indeed, we demonstrated a TMEV-induced strong CXCL10 activity, probably mixed with that of other chemokines also described to attract activated T cells. These biological data confirmed the immunological and molecular findings previously presented in this article. The supernatants were further titrated for induction of migration on cells of the D10 cell line (Fig. 5a ). The numbers on the bars represent the concentration of CXCL10 in each supernatant in nanogram per milliliter, as determined by ELISA. No chemotaxis could be demonstrated at concentrations of 0.16 ng/mL, in a similar way as a concentration of 0.2 ng/mL was the lower limit of activity found for neutrophil chemotaxis due . The number and phenotype of the chemoattracted cells was determined by flow cytometry using anti-CD4 antibodies. The relative proportion of stained cells is indicated, followed by the mean fluorescence intensity (in parentheses), in the upper corners of the quadrant to the chemokine CXCL2/MIP-2, also contained in our astrocyte supernatants (Rubio et al. 2006) . A linear regression analysis of this data produces a line with a slope of 1.915± 0.1570 (Fig. 5b) , indicating that the system was not saturated at our working concentrations and that 100 % migration will theoretically be reached at 48 ng/mL of CXCL10, i.e., using a supernatant concentrated 3-fold. According to our linear regression analysis, the ED 50 of chemotaxis is reached at a CXCL10 concentration of 25 ng/mL, consistent with the data reported for recombinant CXCL10 in the manufacturer's technical data sheet (R&D Systems, Inc.).
Thus, a strong CXCL10 activity was found in the supernatants, which could be mixed with other chemokines also attracting activated T cells. To further quantify the contribution of CXCL10 to the total activity studied here, we neutralized it by increasing concentrations of anti-CXCL10 antibodies (Fig. 5c) . Those antibodies produced a plateau of inhibition of 40±3.27 % activity. So, this value is the contribution of CXCL10 in the mixture of activated T cell-attracting chemokines contained in the infected astrocyte supernatants. As a negative antibody control, a neutralizing antibody against the chemokine CXCL1 was used (Fig. 5c) . Those biological results confirmed the molecular and immunological findings previously presented in this article.
Induction of CXCL10 in astrocytes by inflammatory cytokines
The possible role of four recombinant inflammatory cytokines (IL-1α, IL-6, IFN-γ, and TNF-α) in the upregulation of the chemokine CXCL10 were tested at a concentration of 10 ng/ mL during 48 h, the best conditions for stimulation found previously for brain astrocytes (Rubio and Sanz-Rodriguez 2007) . IFN-γ, IL1α, and TNF-α induced the release of similar amounts of CXCL10 to the supernatants and in quantities similar to those induced by TMEV infection (mean 17± 1.9 ng/mL) which were significantly higher than the amounts of the chemokine secreted by the untreated control cells (Student's t test, P<0.01; see Fig. 3 ). Conversely, exposure to IL-6 did not trigger any upregulation (mean 0.7±0.3 ng/ mL) despite the concentrations used. Significant enhancement of CXCL10 mRNA expression has previously been reported on exposure to IFN-γ but not TNF-α, using the RNase protection assay (Palma and Kim 2001) . It should be noted that the ELISA assay used by us has no significant cross-reactivity with any of the inflammatory cytokines studied here.
CXCL10 in the serum of SJL/J and BALB/c infected mice
To study the pathophysiological relevance of the data presented thus far, we determined the levels of CXCL10 within the CNS compartment by assessing the chemokine levels in CSF from SJL/J and BALB/c infected mice. We were unable to collect enough fluid from individual animals to perform the ELISA test in order to achieve a correct statistical analysis of the results. Therefore, we investigated it by monitoring the changes in CXCL10 serum levels. These levels were significantly increased in infected SJL/J individuals (P<0.01). Those increases were time-dependent with peak levels reaching 119.7 ± 12.4 pg/mL (mean ± SD) 2-3-day postinfection, decreasing thereafter to reach basal levels by day 14. Conversely, a constant background level (mean 36.6± 11.1 pg/mL) was detected in the serum of TMEV-injected BALB/c animals (Fig. 6) .
Inhibition of CXCL10 overexpression by estrogen receptor modulators
Inflammation is a common feature of MS, and recent research results suggest that estrogen receptors may suppress brain (Glass et al. 2010; Amor et al. 2010) . Estradiol and four different SERMs of known antiinflammatory activity were studied in our experimental model of MS. The estrogenic compounds were tested at a concentration of 10 −11 M for 17β-estradiol and 10 −9 M for the other estrogenic molecules, concentrations that were determined previously by titrating the lower physiological concentrations that induced strong inhibitions. Trypan blue uptake indicated that none of the treatments were toxic, as did by the standard qPCR curves obtained for the control housekeeping gene. All the estrogenic compounds produced a clear and significant inhibitory effect on CXCL10 secretion by TMEVinfected astrocytes tested by ELISA (Fig. 7a) . These agents inhibited chemokine secretion to the culture medium by approximately 60 %, and a similar antiinflammatory effect was also evident at the mRNA level (Fig. 7b) . Therefore, the estrogenic compounds tested exerted a strong inhibitory effect on the TMEVinduced astrocyte synthesis and secretion of CXCL10, provoking a quite reproducible and strong antiinflammatory effect.
Discussion CXCL10 (IP-10) induces the trafficking of activated antigenspecific T cells to sites of inflammation , in a similar manner as CXCL12 (SDF-1α) regulates the migration of naive T lymphocytes to secondary lymphoid tissues for activation (Kim and Broxmeyer 1999) . We were interested to determine if astrocytes, the main cell population in the CNS that produces CXCL10 (Asensio et al. 2001) , synthesize greater amounts of this chemokine after TMEV infection. To achieve this, we used cultures that have not been subjected to any "reactive" stimulus, such as previous infection, obtaining the cells from the brain of the germ-free neonates. We speculate that the production of CXCL10 by astrocytes in vitro predicts the recruitment of TMEV-specific activated T cells that cross the blood-brain barrier (BBB) in vivo. We propose that this kind of trafficking happens toward the site of infection and that therefore, CXCL10 plays an important role in the immunological mechanisms that produce demyelination. As a matter of fact, in a mouse hepatitis virus model of MS (Liu et al. 2001) , and following Dengue virus infection (Hsieh et al. 2006) , the neutralization of CXCL10 reduced inflammatory cell invasion and demyelination, followed by an improvement of neurological functions. The DTH reaction demonstrated in the TMEV model (Clatch et al. 1986 ) was also assessed further in the herpes simplex virus type 1 system (Molesworth-Kenyon et al. 2005a, b) , demonstrating that CXCL10 was absolutely required for CD4 + T cell recruitment. Using hybridization to DNA microchip arrays from Affymetrix, we demonstrated the overexpression of genes coding for CXCL10 in murine astrocytes infected with the BeAn virus. These DNA hybridization data were further 
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−11 M for E (estradiol) and 10 −9 M for all the others (tamoxifen, raloxifene, ospemifene, and bazedoxifene). The results represent mean values±SD of quadruplicate samples. Asterisk statistically significant decreases compared to the untreated infected cultures (TMEV), as determined by the Student's t test (P<0.01) validated by RT-PCR and qPCR with specific CXCL10 primers, both techniques confirming the increase in mRNA expression detected. A CXCL10 ELISA test allowed us to quantify the amounts of this chemokine secreted and accumulated in supernatants of TMEV-infected astrocyte cultures. The highest chemokine levels were found when the BeAn virus was used at an m.o.i. of 10, peaking 24 h after infection. Interestingly, BALB/c astrocytes did not produce detectable CXCL10 when infected. BALB/c is a mouse strain resistant to the demyelination induced by TMEV, and its failure to produce a CXCL1/KC chemokine response following viral infection has been reported previously (Rubio and SanzRodriguez 2007) . In terms of susceptibility to TMEV, this strain specificity suggests an important role for astrocytesynthesized chemokines in the genesis of mononuclear immune cell infiltrates currently found in association with demyelination.
The chemokine detected here was biologically active and produced clear chemoattraction for activated T cells in the supernatants of infected astrocyte cultures. Specifically, the murine CD4 + T helper cell clone D10, which is continuously activated in the presence of recombinant IL-2 (Ojeda et al. 1995) , was subject to strong chemoattraction by our supernatants. CXCL10 could coexist in these supernatants with other as yet uncharacterized chemokines to which activated T lymphocytes might also respond, such as CXCL9/Mig (see Systematic nomenclature for chemokines 1999). Nevertheless, our system was not saturated at the maximal concentration of CXCL10 found in the supernatants (around 15 ng/mL) as the extrapolation of the regression line obtained indicated that larger amounts of the chemokine would induce the migration of more D10 cells.
Several inflammatory cytokines also induce CXCL10 synthesis in astrocytes, and while IL-1α, IFN-γ, and TNF-α were strong inducers, IL-6 produced no such effect. The presence of CXCL10 in the serum of infected SJL/J but not of BALB/c mice suggests that this intrathecally synthesized protein fulfills a direct role in the chemoattraction of TMEV-specific activated T cells. In addition to monocyte-macrophages, these cells contribute to the characteristic infiltrates in areas of demyelination. The upregulation of CXCL10 transcripts has also been demonstrated in the spinal cord during the course of TMEV infection in mice (Hoffman et al. 1999) . Again, a strain-dependent difference was demonstrated in BALB/c mice, suggesting an important role for CXCL10 in resistance/susceptibility in demyelination.
By contrast to inflammatory cytokines, we demonstrated a clear downregulation of CXCL10 expression by 17β-estradiol and four SERMs. The inhibition of CXCL10 induction by lipopolysaccharide (LPS) in the presence of SERMs has been reported previously (Cerciat et al. 2010) . This data opens the way for the use of such SERMs in neutralizing CXCL10 production and the ensuing inflammatory cell invasion, thereby improving neurological function, as evident in other models (Liu et al. 2001; Hsieh et al. 2006) .
